P.E. Ebong
Impact in
- Drug Discovery top 2%
-
- Natural Antidiabetic Agents Studies
- Diet, Metabolism, and Disease
Papers in
-
- Natural Antidiabetic Agents Studies 30
- Diet, Metabolism, and Disease 12
- Pharmacology 17
- Drug-Induced Hepatotoxicity and Protection 13
- Co-authors
- Item Justin Atangwho (12 shared papers)Godwin Eneji Egbung (7 shared papers)Daniel Udofia Owu (2 shared papers)F.E. Uboh (12 shared papers)E.U. Eyong (12 shared papers)Mbeh Ubana Eteng (10 shared papers)E. E. Osim (1 shared paper)Godwin Oju Igile (11 shared papers)
In The Last Decade
P.E. Ebong
63 papers receiving 919 citations
Peers
Comparison fields: 5 of 97
- Drug Discovery 5
- Endocrinology, Diabetes and Metabolism 392
- Pharmacology 203
- Biochemistry 110
- Complementary and alternative medicine 98
Countries citing papers authored by P.E. Ebong
This map shows the geographic impact of P.E. Ebong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.E. Ebong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.E. Ebong more than expected).
Fields of papers citing papers by P.E. Ebong
This network shows the impact of papers produced by P.E. Ebong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.E. Ebong. The network helps show where P.E. Ebong may publish in the future.
Co-authors
The 25 scholars most cited alongside P.E. Ebong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 135 | |
| 2 | 2009 | 81 | |
| 3 | 1998 | 80 | |
| 4 | 1999 | 78 | |
| 5 | 2012 | 61 | |
| 6 | 2007 | 60 | |
| 7 | 2007 | 42 | |
| 8 | 2013 | 38 | |
| 9 | 2012 | 36 | |
| 10 | 2013 | 31 | |
| 11 | 2010 | 28 | |
| 12 | 2020 | 24 | |
| 13 | 2007 | 24 | |
| 14 | Extract of Vernonia Amygdalina Del. (African Bitter Leaf) Can Reverse Pancreatic Cellular Lesion after Alloxan Damage in the Rat | 2010 | 23 |
| 15 | Evaluation of toxicological implications of inhalation exposure to kerosene fumes and petrol fumes in rats | 2005 | 22 |
| 16 | 1997 | 21 | |
| 17 | 2009 | 20 | |
| 18 | 2012 | 18 | |
| 19 | 2010 | 17 | |
| 20 | 2009 | 16 |
About P.E. Ebong
P.E. Ebong is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology, Epidemiology, Nutrition and Dietetics and Genetics, having authored 66 papers that have together received 1.1k indexed citations. Recurring topics across this work include Natural Antidiabetic Agents Studies (30 papers), Drug-Induced Hepatotoxicity and Protection (13 papers), Diet, Metabolism, and Disease (12 papers), Advances in Cucurbitaceae Research (8 papers), Liver Disease Diagnosis and Treatment (8 papers), Ethnobotanical and Medicinal Plants Studies (5 papers), Seed and Plant Biochemistry (4 papers) and Coconut Research and Applications (3 papers). The work is most often cited by research in Drug Discovery (5 citations), Endocrinology, Diabetes and Metabolism (392 citations), Pharmacology (203 citations), Biochemistry (110 citations) and Complementary and alternative medicine (98 citations). P.E. Ebong has collaborated with scholars based in Nigeria, Pakistan and Malaysia. Frequent co-authors include Item Justin Atangwho, Godwin Eneji Egbung, Daniel Udofia Owu, F.E. Uboh, E.U. Eyong, Mbeh Ubana Eteng, E. E. Osim, Godwin Oju Igile, Olorunfemi A. Eseyin and I.B. Umoh. Their work appears in journals such as Plant Foods for Human Nutrition, Phytotherapy Research, Journal of Trace Elements in Medicine and Biology, Andrologia and Heliyon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.